查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1987322

樣品製備市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034 年

Sample Preparation Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球樣品製備市場規模為91億美元。展望未來，IMARC Group預測，該市場將以5.05%的複合年成長率從2026年成長至2034年，到2034年達到141.6億美元。目前，北美市場主導地位，預計2025年將佔30%的市場。該地區受益於許多因素，例如：強大的醫藥和生物技術研發基礎設施、先進的基因組學和蛋白​​質組學主導的工作流程的廣泛應用、越來越多的慢性疾病需要精準的分子診斷，以及眾多大型生命科學公司和研究機構的聚集，這些公司和機構正在不斷擴大其在樣品製備市場的佔有率。

全球樣品製備市場正經歷持續成長，這主要得益於多種因素的共同作用。製藥、生物技術和臨床檢查室對質譜、層析法和次世代定序等先進分析技術的日益普及，催生了對高效上游工程樣本處理解決方案的穩定需求。癌症、糖尿病和心血管疾病等慢性病在全球範圍內的日益流行，進一步加劇了對分子診斷的需求，凸顯了樣本製備的關鍵作用。此外，自動化技術的進步正在簡化檢查室工作流程，減少人為錯誤，並提昇科學研究和診斷機構的整體處理能力。個人化醫療和基因組學研究的蓬勃發展，也推動了全球醫療保健、製藥和學術研究等各領域樣本製備市場的成長。

由於多種因素，美國正崛起為樣品製備市場的領先地區。其高度發展的生命科學生態系統，包括緊密的製藥公司、生物技術公司和學術研究中心網路，正在持續推動對可靠樣品製備解決方案的需求成長。對精準醫療和基因組學主導型研究計畫的大量投資，正在加速臨床和研究領域對先進樣本製備設備和試劑盒的採用。聯邦機構強制執行的監管標準要求嚴格的分析程序，鼓勵在藥物研發、食品安全檢測和環境監測中使用標準化的樣品製備和調查方法。美國國家癌症研究所 (NCI) 預測，到 2025 年，美國將新增約 200 萬例癌症病例，這將持續推動對依賴高效樣品製備的分子診斷和基因組分析工作流程的需求。隨著實驗室自動化在商業和學術研究環境中的持續加速應用，美國樣品製備市場的前景仍然十分光明。

樣品製備市場的發展趨勢：

擴大實驗室工作流程的自動化程度

全球樣品製備市場正受到自動化技術快速融入實驗室工作流程的影響。隨著製藥、生物技術和臨床檢查室擴大營運規模以滿足日益成長的診斷和研究需求，人工樣本處理正逐漸被自動化系統所取代，從而提升處理能力、可重複性和一致性。自動化平台在高通量實驗室環境中變得至關重要，因為它們可以降低交叉污染的風險，最大限度地減少操作人員的差異，並實現多個樣品的同步處理。智慧液體處理系統、萃取工作站和模組化自動化平台的開發顯著擴展了實驗室操作人員的能力。這些系統與數位連接解決方案的整合日益增強，從而實現了跨分散式實驗室網路的遠端監控、軟體更新和數據追蹤。人工智慧在自動化儀器中的日益普及，使得能夠實現適應檢體基質變化的自最佳化通訊協定。 2025年4月，凱傑公司宣布分階段推出新一代自動化樣品製備系統QIAsymphony Connect。該系統可同時處理多達 96 個檢體，並具有增強的數位連接性和改進的自動化功能，適用於腫瘤學、基因組學和臨床研究工作流程，進一步鞏固了這些領域以自動化主導的成長軌跡。

製藥和生物技術領域的擴張

製藥和生物技術產業是推動全球樣品製備市場發展的主要驅動力之一。隨著新藥發現、生物製藥開發和個人化醫療的不斷推進，對準確、可靠和標準化的樣品製備的需求顯著成長。分離、純化和濃縮蛋白質、核酸和代謝物以進行下游分析的需求對藥物開發過程至關重要，能夠確保研究各個階段的數據完整性和可重複性。作為現代生物製藥研究基礎的基因組學和蛋白​​質組學分析，需要精細的上游處理以維持樣本品質並最大限度地減少分析干擾。嚴格的藥物開發監管框架使得檢驗的樣品製備通訊協定成為確保符合數據完整性標準的關鍵。隨著液態生物檢體和無細胞DNA提取技術的日益普及，新的非侵入性診斷領域正在湧現，對高精度樣品製備提出了更高的要求。世界衛生組織（WHO）的數據顯示，非傳染性疾病約佔全球死亡總數的74%，凸顯了國際社會對先進分子診斷及其相關樣本製備技術的迫切需求。

對環境和食品安全檢測的需求日益成長

環境監測和食品安全檢測範圍的不斷擴大是全球樣品製備市場預測的關鍵促進因素。隨著全球監管機構收緊對污染物、農藥、重金屬和食源性病原體的容許限值，對高靈敏度和高可靠性分析方法的需求顯著成長。水、土壤和空氣顆粒等環境樣本含有複雜的基質，需要在儀器分析前進行徹底的萃取、純化和濃縮。同樣，食品中過敏原、添加劑和假標記物的檢測也需要精細的樣品製備，以達到符合監管要求的靈敏度。固相萃取、分散固相萃取和QuEChERS調查方法的進步，擴展了環境和食品安全領域專業人員可用的分析工具。對小型化和高通量樣品製備方法的需求日益成長，能夠縮短處理時間並減少溶劑消耗，有助於實現成本效益和永續性目標。 2025年，新英格蘭生物實驗室（NEB®）宣布推出NEBNext低偏倚小RNA文庫製備試劑盒，旨在減少定序結果中小RNA類型的偏倚表達。與市售其他試劑盒相比，這種新一代小RNA製備方法更快、偏倚更小，並且支援更廣泛的起始樣本量。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球樣品製備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 樣品製備裝置
    • 主要部分
      • 提取系統
      • 工作站
      • 自動蒸發系統
      • 液體處理設備
      • 其他
  • 消耗品
  • 樣品製備試劑盒
    • 主要部分
      • 淨化套件
      • 隔離試劑盒
      • 提取套件

第7章 市場區隔：依應用領域分類

  • 蛋白質體學
  • 基因組學
  • 表觀基因
  • 其他

第8章 市場區隔：依最終用戶分類

  • 製藥和生物技術公司
  • 食品飲料業
  • 研究機構和學術機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Agilent Technologies Inc
    • Bio-Rad Laboratories, Inc.
    • Biotage
    • F. Hoffmann-La Roche Ltd
    • Hamilton Company
    • Norgen Biotek Corp.
    • PerkinElmer Inc.
    • Phenomenex Inc.（Danaher Corporation）
    • Qiagen NV
    • Restek Corporation
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A6241

The global sample preparation market size was valued at USD 9.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.16 Billion by 2034, exhibiting a CAGR of 5.05% from 2026-2034. North America currently dominates the market, holding a market share of 30% in 2025. The region benefits from its robust pharmaceutical and biotechnology research and development (R&D) infrastructure, widespread adoption of advanced genomics and proteomics-driven workflows, the growing prevalence of chronic diseases requiring precise molecular diagnostics, and the strong concentration of leading life sciences enterprises and research institutions expanding the sample preparation market share.

The global sample preparation market is experiencing sustained growth driven by multiple converging forces. The increasing adoption of advanced analytical techniques, including mass spectrometry, chromatography, and next-generation sequencing across pharmaceutical, biotechnology, and clinical laboratories, is creating consistent demand for efficient upstream sample processing solutions. The rising global prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is intensifying the demand for molecular diagnostics, underscoring the critical role of sample preparation. Furthermore, advancements in automation technologies are streamlining laboratory workflows, reducing human error, and enhancing throughput across research and diagnostic facilities. The surge in personalized medicine initiatives and genomics research is also supporting the sample preparation market growth across diverse healthcare, pharmaceutical, and academic research verticals worldwide.

The United States has emerged as a major region in the Sample Preparation market owing to many factors. The country's highly developed life sciences ecosystem, encompassing a dense network of pharmaceutical companies, biotechnology firms, and academic research centers, creates a consistent and growing demand for reliable sample preparation solutions. Significant investment in precision medicine and genomics-driven research programs has accelerated the adoption of advanced sample preparation instruments and kits across clinical and research settings. Regulatory standards enforced by federal agencies mandate rigorous analytical procedures, reinforcing the use of standardized sample preparation methodologies in drug development, food safety testing, and environmental monitoring. According to the National Cancer Institute (NCI), approximately 2 million new cancer diagnoses are expected in the United States in 2025, sustaining demand for molecular diagnostics and genomic profiling workflows that depend on effective sample preparation. The sample preparation market outlook in the United States remains highly positive as laboratory automation adoption continues to accelerate across both commercial and academic research environments.

SAMPLE PREPARATION MARKET TRENDS:

Expanding Automation in Laboratory Workflows

The global sample preparation market is significantly shaped by the rapid integration of automation into laboratory workflows. As pharmaceutical, biotechnology, and clinical laboratories scale their operations to meet growing diagnostic and research demands, manual sample processing is increasingly being replaced by automated systems that deliver enhanced throughput, reproducibility, and consistency. Automated platforms reduce the risk of cross-contamination, minimize operator-dependent variability, and enable simultaneous processing of multiple samples, making them indispensable in high-volume laboratory settings. The development of intelligent liquid handling systems, extraction workstations, and modular automation platforms has greatly expanded the capabilities available to laboratory operators. These systems are increasingly integrated with digital connectivity solutions, enabling remote monitoring, software updates, and data tracking across distributed laboratory networks. The growing adoption of artificial intelligence within automated instruments is enabling self-optimizing protocols that adapt to sample matrix variability. In April 2025, QIAGEN announced the phased launch of its next-generation QIAsymphony Connect automated sample preparation system, capable of processing up to 96 samples simultaneously with enhanced digital connectivity and improved automation capabilities for oncology, genomics, and clinical research workflows, reinforcing the trajectory of automation-led growth in the sector.

Pharmaceutical and Biotechnology Sector Expansion

The pharmaceutical and biotechnology sectors are among the primary drivers shaping the sample preparation market trends globally. As novel drug discovery, biologics development, and personalized medicine initiatives proliferate, the demand for accurate, reliable, and standardized sample preparation has intensified considerably. The need to isolate, purify, and concentrate proteins, nucleic acids, and metabolites for downstream analyses is fundamental to the drug development process, ensuring data integrity and reproducibility across all research stages. Genomic and proteomic profiling, which form the backbone of modern biopharmaceutical research, require meticulous upstream processing to maintain sample quality and minimize analytical interference. Stringent regulatory frameworks governing drug development necessitate validated sample preparation protocols that ensure compliance with data integrity standards. The increasing focus on liquid biopsy and cell-free DNA extraction is opening new frontiers for non-invasive diagnostics that demand precision-grade sample processing. According to the World Health Organization, non-communicable diseases account for approximately 74% of all deaths globally, elevating the international urgency for advanced molecular diagnostics and the sample preparation technologies that support their development.

Rising Environmental and Food Safety Testing Demands

The expanding scope of environmental monitoring and food safety testing is a critical driver of the global sample preparation market forecast. As regulatory agencies worldwide tighten permissible limits for contaminants, pesticides, heavy metals, and foodborne pathogens, the requirement for highly sensitive and reliable analytical methods has escalated substantially. Environmental samples such as water, soil, and air particulates involve complex matrices that necessitate thorough extraction, cleanup, and concentration before instrument-based analysis. Similarly, the detection of allergens, additives, and adulteration markers in food products demands meticulous sample preparation to achieve the sensitivity required for regulatory compliance. Advances in solid-phase extraction, dispersive solid-phase extraction, and QuEChERS methodologies have expanded the analytical toolkit available to professionals in environmental and food safety disciplines. The growing demand for miniaturized and high-throughput sample preparation formats is enabling faster turnaround times and lower solvent consumption, supporting both cost efficiency and sustainability goals. In 2025, New England Biolabs (NEB(R)) has announced the introduction of the NEBNext Low-bias Small RNA Library Prep Kit, aimed at reducing biased representation of small RNA types in sequencing results. This next generation method for preparing small RNA is quicker, less biased, and accommodates a wider input range compared to other kits available for purchase.

SAMPLE PREPARATION INDUSTRY SEGMENTATION:

Analysis by Product:

  • Sample Preparation Instruments
    • Extraction System
    • Workstation
    • Automated Evaporation System
    • Liquid Handling Instrument
    • Others
  • Consumables
  • Sample Preparation Kit
    • Purification Kit
    • Isolation Kit
    • Extraction Kit

Sample preparation Instruments holds 40% of the market share. Sample preparation instruments comprise the specialized equipment used to process, extract, purify, and transform biological and chemical specimens into analytically suitable formats across diverse laboratory applications. These instruments include extraction systems, liquid handling platforms, automated workstations, and evaporation units, each engineered to address specific stages of the sample processing workflow with precision and efficiency. The dominance of this segment is driven by the widespread integration of automation in laboratory environments, where instrument-based systems replace manual, time-intensive protocols, delivering enhanced throughput, consistency, and reproducibility. Pharmaceutical and biotechnology laboratories rely extensively on these instruments for nucleic acid extraction, protein isolation, and metabolite profiling fundamental to drug discovery and clinical research pipelines. The growing adoption of digitally connected and modular instrument platforms capable of interfacing with laboratory information management systems is further expanding their utility.

Analysis by Application:

  • Proteomics
  • Genomics
  • Epigenomics

Genomics leads the market with a share of 36%. Genomics represents the study, analysis, and sequencing of complete genetic material to understand structure, function, and evolution across organisms. As a primary application for sample preparation technologies, genomics encompasses DNA extraction, RNA isolation, library preparation for next-generation sequencing, and nucleic acid purification, all of which demand high-quality upstream specimen processing. The widespread adoption of genomics in drug discovery, disease diagnosis, agricultural biotechnology, and personalized medicine continues to propel demand for specialized sample preparation kits and instruments. Standardized and validated sample preparation protocols are essential to maintaining nucleic acid integrity and reproducibility in genomic analyses, directly influencing the reliability of downstream sequencing results. The integration of genomics into routine clinical diagnostics, including liquid biopsy and hereditary disease screening, is further expanding application scope. The expanding sample preparation market forecast reflects the increasing centrality of genomics across healthcare and research sectors globally.

Analysis by End User:

  • Pharmaceutical or Biotechnology Companies
  • Food and Beverages Industry
  • Research and Academic Institutes

Pharmaceutical or biotechnology companies dominates the market, with a share of 35%. Pharmaceutical and biotechnology companies represent the leading end-user segment in the sample preparation market, driven by their extensive reliance on robust, standardized sample processing workflows across every stage of the drug development lifecycle. From early-stage target identification and lead optimization to preclinical testing and clinical validation, these organizations require precise sample preparation to ensure the accuracy, reproducibility, and regulatory compliance of analytical data. The extraction and purification of proteins, nucleic acids, lipids, and small molecules are routine activities within pharmaceutical and biotechnology laboratories, where sample quality directly impacts the validity of research outcomes. Increasing investments in biologics development, gene therapies, and mRNA-based therapeutics are intensifying demand for specialized purification kits and automated preparation instruments capable of handling complex biological matrices.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 30% of the share, enjoys the leading position in the market. North America's leadership in the global sample preparation market is underpinned by a convergence of structural advantages, including the world's largest concentration of pharmaceutical and biotechnology companies, a highly developed academic research infrastructure, and strong federal funding for life sciences and genomics programs. The region's advanced laboratory ecosystem supports widespread adoption of automated sample preparation platforms enabling high-throughput processing essential for clinical diagnostics, drug development, and environmental monitoring. Regulatory requirements from agencies including the U.S. FDA and Health Canada ensure standardized sample preparation procedures are deeply embedded in the workflows of both commercial and academic laboratories. The growing emphasis on personalized medicine, proteomics-based diagnostics, and liquid biopsy applications further drives innovation and investment in sample preparation technologies throughout the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SAMPLE PREPARATION MARKET ANALYSIS

The United States represents the most significant individual country market for sample preparation globally, characterized by the highest concentration of pharmaceutical and biotechnology enterprises, research universities, and government-funded genomics and precision medicine programs. The robust clinical laboratory infrastructure across the country supports high-volume testing for cancer screening, infectious disease diagnosis, and genetic counseling, all fundamentally underpinned by advanced sample preparation workflows. Growing adoption of next-generation sequencing in both research and clinical settings is generating sustained demand for nucleic acid extraction kits, liquid handling systems, and automated extraction platforms capable of processing large sample batches. Federal initiatives supporting genomics-based healthcare, administered through agencies including the National Institutes of Health and the National Cancer Institute, continue to fund research programs that directly stimulate sample preparation technology adoption across academic medical centers and commercial laboratories. The FDA's mandate for validated sample preparation procedures in pharmaceutical testing, diagnostics, and food safety creates a consistent and structured demand environment. In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are expected to take place in the United States., reinforcing the country's leading role in precision oncology and molecular diagnostics and driving sustained sample preparation market growth across clinical and research settings.

EUROPE SAMPLE PREPARATION MARKET ANALYSIS

Europe represents the second-largest regional market for sample preparation, supported by a sophisticated network of research institutions, pharmaceutical manufacturers, and academic laboratories distributed across the continent. The European life sciences sector benefits from well-established regulatory frameworks administered by the European Medicines Agency, which mandate standardized sample preparation in drug development and quality control processes. Significant national and cross-border investment in genomics and proteomics research, along with expanding clinical diagnostics networks, reinforces demand for high-quality sample preparation instruments and consumables. Countries including Germany, the United Kingdom, France, and Switzerland host major pharmaceutical research hubs where advanced analytical workflows are integral to daily operations. The continent's growing focus on precision medicine and aging population-driven healthcare demands are expanding the need for molecular diagnostics and associated sample preparation technologies. According to the European Commission's Horizon Europe research program, health research received an allocation of approximately EUR 8.246 billion across the program's operational period, with significant funding directed toward genomics, oncology research, and molecular diagnostics that drive adoption of advanced sample preparation technologies across European laboratories.

ASIA-PACIFIC SAMPLE PREPARATION MARKET ANALYSIS

Asia-Pacific is among the fastest-growing regional markets for sample preparation, propelled by rapid expansion in pharmaceutical manufacturing, biotechnology research, and clinical diagnostics infrastructure. Countries such as China, India, Japan, South Korea, and Australia are investing heavily in life sciences R&D, with government-backed innovation programs fueling laboratory equipment procurement. The increasing burden of chronic diseases and infectious illnesses is amplifying demand for molecular diagnostic tools that rely on effective sample preparation workflows. The growth of contract research organizations and pharmaceutical contract manufacturing organizations in the region is further accelerating adoption of automated sample preparation platforms. Union Budget 2026-27 suggested the Biopharma SHAKTI with a budget of Rs. 10,000 crores across five years, focused on enhancing India's framework for the manufacture of biologics and biosimilars, creating a growing pipeline for laboratory sample preparation technologies across research and manufacturing facilities in the country.

LATIN AMERICA SAMPLE PREPARATION MARKET ANALYSIS

Latin America is an emerging market for sample preparation, driven by growing investments in healthcare infrastructure, pharmaceutical production, and academic research across key economies including Brazil and Mexico. The rising burden of infectious diseases and chronic conditions such as cancer and diabetes is creating increased demand for molecular diagnostics and the sample preparation workflows that support them. Government healthcare reforms aimed at expanding diagnostic testing capacity are reinforcing laboratory equipment adoption across the region. Academic institutions and public health laboratories are increasingly seeking automated and kit-based sample preparation solutions to improve testing efficiency and data quality.

MIDDLE EAST AND AFRICA SAMPLE PREPARATION MARKET ANALYSIS

The Middle East and Africa represent an emerging market for sample preparation, driven by expanding healthcare investments and the growing establishment of diagnostic laboratories across the region. Government-led healthcare modernization programs in Gulf Cooperation Council countries and South Africa are creating new demand for laboratory automation and molecular diagnostics platforms. The increasing prevalence of infectious diseases and non-communicable conditions, along with the expansion of pharmaceutical manufacturing in selected markets, are further creating avenues for sample preparation adoption. Rising investments in academic and clinical research infrastructure are opening new opportunities for instrument and consumable procurement across public and private healthcare sectors.

COMPETITIVE LANDSCAPE:

The global sample preparation market is characterized by intense competition among a diverse group of established life sciences companies, specialty laboratory suppliers, and emerging technology providers. Key players are focused on product innovation, strategic mergers and acquisitions, and the development of integrated automation platforms that combine instruments with proprietary reagents and consumables to create comprehensive end-to-end sample preparation solutions. Competition is shaped by the ability to deliver validated, regulatory-compliant workflows that meet the evolving demands of pharmaceutical, clinical, and environmental laboratories. Leading companies are also leveraging digital connectivity, artificial intelligence, and cloud-based monitoring to differentiate their instrument platforms and drive customer retention through ecosystem lock-in. Strategic investments in emerging markets, particularly within the Asia-Pacific and Latin American regions, are intensifying as established players seek to capture growing laboratory infrastructure demand. The increasing convergence of sample preparation with advanced sequencing and diagnostics platforms is reshaping competitive boundaries and creating opportunities for cross-segment innovation partnerships across the market.

The report provides a comprehensive analysis of the competitive landscape in the sample preparation market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc
  • Bio-Rad Laboratories, Inc.
  • Biotage
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Norgen Biotek Corp.
  • PerkinElmer Inc.
  • Phenomenex Inc. (Danaher Corporation)
  • Qiagen N.V.
  • Restek Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the sample preparation market?

2. What is the future outlook of the sample preparation market?

3. What are the key factors driving the sample preparation market?

4. Which region accounts for the largest sample preparation market share?

5. Which are the leading companies in the global sample preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sample Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Sample Preparation Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Extraction System
      • 6.1.2.2 Workstation
      • 6.1.2.3 Automated Evaporation System
      • 6.1.2.4 Liquid Handling Instrument
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sample Preparation Kit
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Purification Kit
      • 6.3.2.2 Isolation Kit
      • 6.3.2.3 Extraction Kit
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Proteomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Genomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Epigenomics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical or Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Food and Beverages Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotage
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Hamilton Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Norgen Biotek Corp.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 PerkinElmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Phenomenex Inc. (Danaher Corporation)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Restek Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Tecan Trading AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Sample Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Sample Preparation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Sample Preparation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Sample Preparation Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Sample Preparation Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Sample Preparation Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Sample Preparation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Sample Preparation (Sample Preparation Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Sample Preparation (Sample Preparation Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Sample Preparation (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Sample Preparation (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Sample Preparation (Sample Preparation Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Sample Preparation (Sample Preparation Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Sample Preparation (Proteomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Sample Preparation (Proteomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Sample Preparation (Genomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Sample Preparation (Genomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Sample Preparation (Epigenomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Sample Preparation (Epigenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Sample Preparation (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Sample Preparation (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Sample Preparation (Pharmaceutical or Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Sample Preparation (Pharmaceutical or Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Sample Preparation (Food and Beverages Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Sample Preparation (Food and Beverages Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Sample Preparation (Research and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Sample Preparation (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Sample Preparation (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Sample Preparation (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Sample Preparation Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Sample Preparation Industry: SWOT Analysis
  • Figure 80: Global: Sample Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Sample Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sample Preparation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Sample Preparation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Sample Preparation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Sample Preparation Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Sample Preparation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Sample Preparation Market: Competitive Structure
  • Table 7: Global: Sample Preparation Market: Key Players